In view of our data demonstrating a role for medin in driving age-associated vascular dysfunction3 as well as CAA (in this Article), we therefore propose that targeting medin might provide a novel therapeutic approach to preserving brain function during ageing and Alzheimer’s disease by improving vascular health. This evidence concerns the gene MFGE8 and Alzheimer disease.